Stay up to date with the latest news, research, and pharmacy industry trends from CarelonRx
Other essential resources
Consultant resources
You’re the engine that drives benefit solutions
We value the relationship we have with consultants and want to do everything we can to help them serve their clients and grow their business. Take a look at just some of the resources available to consultants and their clients.
Solutions
Specialty drug solutions
SpecialtyRx Savings Navigator helps clients manage their specialty drug spend across medical and pharmacy. They’ll benefit from predictive modeling and forecasting tools. And they’ll receive tailored product and benefit recommendations. The result is informed and improved planning and budgeting.
Affordability solutions
With Cost Relief, members can access available manufacturer copay assistance program funds through a high-touch enrollment experience. This allows us to reduce the cost for certain specialty drugs, which can result in significant savings for members when they enroll.
EnsureRx is free for CarelonRx plan members. They use their pharmacy member ID card at a retail pharmacy as usual, and EnsureRx applies the lowest price available to them on select generic medications.
Evidence-first formulary management
CarelonRx is dedicated to offering high-quality prescription drugs and therapies backed by clinical evidence of improving health, while discouraging the use of non-essential or waste-inducing drugs. This approach results in a total cost of care win for plan members and plan sponsors.
Our drug lists and clinical policies are the product of a rigorous review by our team of pharmacists in conjunction with an independent pharmacy and therapeutics — or P&T — committee.
This committee uses evidence-based medicine to evaluate clinical science and literature. Safety, side effects, and tolerability are just a few of the factors taken into consideration when identifying health-promoting, clinically superior drugs.
Drug and Biologic Pipeline
This quarterly report informs you of upcoming Food and Drug Administration (FDA) approvals. It also analyzes drugs and biologics in development and other clinical topics of interest.
Drug Insights
Your quarterly summary of FDA-approved new molecular entities, formulations, and indications. We closely monitor the FDA landscape to provide an understanding of the current drug and biologic market. (this needs to link to the perspective page)
Newsletter
The CarelonRx monthly newsletter provides short summaries and links to all the stories and clinical reports made available on carelonrx.com throughout the month. (this should link to the subscribe link)
Public policy updates
Take a look at the healthcare and PBM issues we expect federal and state legislators and regulators to focus on.
